Location History:
- San Fruttuoso di Monza, IT (1987)
- Monza, IT (1988 - 2017)
Company Filing History:
Years Active: 1987-2017
Title: Innovations and Contributions of Alberto Milanese
Introduction
Alberto Milanese is a notable inventor based in Monza, Italy. He has made significant contributions to the field of chemistry, particularly in the development of novel methods and complexes that enhance pharmaceutical formulations. With a total of four patents to his name, Milanese has demonstrated a commitment to innovation and scientific advancement.
Latest Patents
Milanese's latest patents include a method of esterification of carboxyl groups present on multihydroxyl cyclic polyene molecular structures carrying basic nitrogen groups. This process involves the preparation of partricin alkyl esters by reacting partricin in a solvent with primary alkyl alcohols in the presence of carbodiimides, along with optional acylation catalysts and/or nitrogen bases or anhydrous acids. Another significant patent is for a complex of amorphous tomoxiprole and cyclodextrin with a fast dissolution rate. This stable complex, formed with 2-hydroxypropyl-beta-cyclodextrin, shows a remarkably faster dissolution rate and absorption compared to crystalline tomoxiprole, making it particularly suitable for pharmaceutical oral dosage forms that require rapid therapeutic action.
Career Highlights
Throughout his career, Milanese has worked with Rottapharm Spa, where he has contributed to various innovative projects. His work has focused on enhancing the efficacy and delivery of pharmaceutical compounds, showcasing his expertise in the field.
Collaborations
Milanese has collaborated with notable professionals in his field, including Riccardo Stradi and Derio Desideri. These collaborations have further enriched his research and development efforts, leading to impactful innovations.
Conclusion
Alberto Milanese's contributions to the field of chemistry and pharmaceuticals are noteworthy. His innovative patents and collaborations reflect his dedication to advancing scientific knowledge and improving therapeutic solutions.